Volume 14, number 2
 PDF Downloads: 1366

Comparative Clinical Trial on the Efficacy and Tolerability of Esomeprazole Versus Rabeprazole in Gastro Esophageal Reflux Disease – A Long Term Study.

Vedamanickam R1, Vinoth Kumar2 and Nagendran Dinakaran3

1Department of  Medicine, Sree Balaji Medical College and Hospital,  Chrompet, Chennai – 600044.

2MGE, Sree Balaji Medical College and Hospital,  Chrompet, Chennai – 600044.

3Senior Consultant Gastro Enterologist.

Corresponding Author E-mail: mmdentalcare77@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/2518

ABSTRACT: Gastroesophageal reflux disease (GERD) represents a wide spectrum of clinical symptoms. Apart from reflux damage of oescophageal mucosa, it reflects sense of ill feeling and quality of life both physically and psychologically. The key factor in the pathogenesis is exposure of the gastric acid into the oesophageal mucosa in GERD. Various therapeutic modalities are available for the treatment of GERD among which proton pump inhibitors (PPI) hold the key. As a class these drugs are extremely safe and efficient in short term therapy. But reports on its long term efficacy are very few in Indian literature. This study stresses the long term efficacy of PPIs in GERD.

KEYWORDS: Gastroesophageal; pathogenesis; modalities

Download this article as: 
Copy the following to cite this article:

Vedamanickam R, Kumar V, Dinakaran N. Comparative Clinical Trial on the Efficacy and Tolerability of Esomeprazole Versus Rabeprazole in Gastro Esophageal Reflux Disease – A Long Term Study. Biosci Biotech Res Asia 2017;14(2).

Copy the following to cite this URL:

Vedamanickam R, Kumar V, Dinakaran N. Comparative Clinical Trial on the Efficacy and Tolerability of Esomeprazole Versus Rabeprazole in Gastro Esophageal Reflux Disease – A Long Term Study. Biosci Biotech Res Asia 2017;14(2). Available from: https://www.biotech-asia.org/?p=25939

[ HTML Full Text]

Back to TOC